FIELD: medicine.
SUBSTANCE: present group of inventions relates to medicine, particularly to endocrinology. For this purpose sufficient amounts of a compound which inhibits HIF hydroxylase activity are introduced.
EFFECT: design of a method of treating diabetes and other conditions, related to glucose pathometabolism, through stabilisation of HIFα.
8 cl, 12 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| FAT CONTENT REGULATION | 2008 |
|
RU2397766C2 |
| FAT CONTENT CONTROL | 2003 |
|
RU2346688C2 |
| NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND USE THEREOF IN INCREASING ENDOGENOUS ERYTHROPOIETIN | 2004 |
|
RU2379291C2 |
| CYANOISOQUINOLINE COMPOUNDS (VERSIONS), PHARMACEUTICAL COMPOSITION BASED THEREON, HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE INHIBITING METHOD AND METHOD OF TREATING AND/OR PREVENTING HIF-ASSOCIATED CONDITION AND/OR ERYTHROPOIETIN-AND/OR ANAEMIA-ASSOCIATED CONDITION | 2007 |
|
RU2457204C2 |
| APPLICATION OF STABILISERS OF HIF- ALPHA FOR INTENSIFICATION OF ERYTHROPOIESIS | 2004 |
|
RU2414214C2 |
| 4-PHENOXY-NICOTANIMIDES OR 4-PHENOXY-PYRIMIDINE-5-CARBOXAMIDES | 2011 |
|
RU2565077C2 |
| 1,1,1-TRIFLUORO-2-HYDROXY-3-PHENYLPROPANE DERIVATIVES | 2008 |
|
RU2481333C2 |
| PYRAZOLO[1,5-a]PYRIMIDINE AND THIENO[3,2-b]PYRIMIDINE DERIVATIVES AS MODULATORS OF IRAK-4 | 2011 |
|
RU2604062C2 |
| PROLYL HYDROXYLASE INHIBITORS AND APPLICATION METHODS THEREOF | 2007 |
|
RU2429226C9 |
| NEW BICYCLIC LIPASE HORMONES INHIBITORS | 2003 |
|
RU2325385C2 |
